Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents in Belgium

NCT04738695 is registered in ClinicalTrials.gov with Sciensano as lead sponsor.

NCT NCT04738695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04738695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents in Belgium
Lead sponsor
Sciensano
Phase
Observational
Overall status
Completed
Start date
February 1, 2021
Completion date
December 31, 2022
Enrollment
3,008 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov-2 infection